Abstract:Background: Proliferative verrucous leukoplakia (PVL) is a rare and refractory form of oral leukoplakia. The etiology of PVL remains unknown. The lesion is characterized by a high rate of malignant transformation. There is no definitive treatment for PVL. Methods: This case study presents a patient diagnosed in 2000 with a localized hyperkeratinized/verrucous lesion involving the facial gingivae of teeth #6-#8. Over the next 24 years, the lesion was biopsied five times. Further, two attempts to ablate the lesion with a CO2 laser (10.6 µm wavelength) were performed. Both ablation treatments were unsuccessful as the lesion recurred and progressed to involve more areas of gingival tissue. To date, biopsy has not revealed transformation into verrucous or squamous cell carcinoma (SCCA). Results: This case study demonstrates that two attempts at ablation of PVL using a CO2 laser had no short- or long-term benefit. The patient eventually lost all maxillary teeth due to root caries and inability to maintain adequate oral hygiene. The PVL lesion currently involves the entire maxillary edentulous ridge, extending from the 2nd molar site to the opposite corresponding site. During the 24 years encompassed by this report, the patient has not experienced a malignant transformation. Conclusion: The results of CO2 laser ablation of the PVL lesion in this case provided no short- or long-term benefit. Given the potential for a sinister outcome, PVL patients require frequent clinical evaluation and biopsy for early detection of a malignant transformation into oral verrucous or SCCA. Key points: Proliferative verrucous leukoplakia (PVL) is a clinical diagnosis and represents a refractory form of multifocal oral mucosal leukoplakia of unknown origin. Currently, there is no reliable and successful treatment for PVL. PVL may undergo transformation to a verrucous or squamous cell carcinoma, thereby necessitating frequent oral examination and biopsy of sinister-appearing mucosal sites. Plain language summary: Proliferative verrucous leukoplakia (PVL) is a rare disorder that affects the gum tissue around the teeth. PVL is a pre-cancerous disorder for which the cause is unknown and there is no treatment that yields a consistently successful result. This case study presents a patient diagnosed in 2000 with PVL involving the facial gum tissue of the upper right cuspid, lateral, and central incisor teeth. Over the next 24 years, the lesion was biopsied five times and two attempts to irradicate the lesion with a CO2 laser were performed. All attempts at treatment were unsuccessful and the lesion slowly progressed to involve more areas of gum tissue. The last biopsy taken in February 2024 did not reveal any areas of developing cancer. During the 24 years covered in this report, the patient did not develop oral cancer. However, treatment with the CO2 laser afforded no measurable benefit. Given the potential for developing cancer of the gum tissues, PVL patients should receive frequent oral exams and periodic biopsies for the detection of early cancer.

Photodynamic therapy combined with laser drilling successfully prevents the recurrence of refractory oral proliferative verrucous leukoplakia

Laser-assisted Photodynamic Therapy in Proliferative Verrucous Oral Leukoplakia

Photodynamic therapy for extensive oral verrucous/granular leukoplakia with moderate-to-severe dysplasia: A case study

5-Aminolevulinic Acid Photodynamic Therapy for Extensive Oral Leukoplakia with Concomitant Oral Submucous Fibrosis: A Case Report

Topical 5-Aminolevulinic Acid-Mediated Photodynamic Therapy for Oral Verrucous Hyperplasia, Oral Leukoplakia and Oral Erythroleukoplakia

Topical photodynamic therapy is very effective for oral verrucous hyperplasia and oral erythroleukoplakia.

Potential of Photodynamic Therapy as a Minimally Invasive Treatment for Oral Verrucous Carcinoma

Treatment of Oral Refractory Large Area Mucosal Leukoplakia with CO2 Laser Combined with Photodynamic Therapy: Case Report.

Eradication of proliferative verrucous leukoplakia with toll-like receptor 7 agonist (topical imiquimod): a case report

Successful Treatment of Large Area Oral Verrucous Hyperplasia Using Diode Laser Ablation Combined with Photodynamic Therapy: A Case Report.

Management of Oral Leukoplakia by Ablative Fractional Laser-Assisted Photodynamic Therapy: A 3-Year Retrospective Study of 48 Patients.

Successful Treatment of Oral Verrucous Hyperplasia with Topical 5-Aminolevulinic Acid-Mediated Photodynamic Therapy

The Combination of Photodynamic Therapy and Fractional CO2 Laser for Oral Leukoplakia: Case Series.

Ablative Fractional Laser-Assisted Photodynamic Therapy Vs. Ablative Fractional Laser for Oral Leukoplakia Treatment: a Randomized, Controlled Pilot Study.

[Research Progress in the Diagnosis and Management of Proliferative Verrucous Leukoplakia].

Proliferative verrucous leukoplakia: Case study of 24 years and outcome of treatment with CO2 laser

Successful Treatment of an Extensive Verrucous Carcinoma with Topical 5-Aminolevulinic Acid-Mediated Photodynamic Therapy.

Primary Clinical Evaluation of Photodynamic Therapy with Oral Leukoplakia in Chinese Patients

Efficacy of a New Therapeutic Option for Vulvar Intraepithelial Neoplasia: Superficial Shaving Combined with Photodynamic Therapy

Combined Ablative Fractional Er ∶ YAG Laser and 10％ ALA-PDT in Treatment of Refractory Verruca Plana

Clinical efficacy of photodynamic therapy of oral potentially malignant disorder